Editorial Review

Kidney International (1991) 40, 389–399; doi:10.1038/ki.1991.224

Primary hyperoxaluria: Therapeutic strategies for the 90's

Jon I Scheinman1

1Durham, North Carolina, USA

Correspondence: Jon I Scheinman MD, Pediatric Nephrology, Duke University Medical Center, P.O. Box 3959, Durham, North Carolina 27710, USA.

Received 29 May 1990; Revised 6 November 1990; Accepted 6 November 1990.

Top

References

  1. Danpure CJ: Recent advances in the understanding, diagnosis and treatment of primary hyperoxaluria type I. J Inher Metab Dis 12:210–224, 1989
  2. Hillman RE: Primary hyperoxalurias, in The Metabolic Basis of Inherited Disease edited by Scrive CR, Beaudet AL, Sly SW, Valle D, New York, McGraw-Hill, 1989, pp. 933–943
  3. Williams HE: Oxalic acid and the hyperoxaluric syndromes. Kidney Int 13:410–417, 1978
  4. Williams HE, Smith LH: Primary hyperoxaluria, in The Metabolic Basis of Inherited Disease (5th ed), edited by Stanbury JR, Wyngaarden JB, New York, McGraw-Hill, 1983
  5. Oxalate Metabolism in Relation to Urinary Stone. Edited by Rose GA, New York, Springer-Verlag, 1988
  6. Rose GA: Mild metabolic hyperoxaluria. A new syndrome, (ibid pp. 121–130)
  7. Noel C, Sault M, Dhondt J, Gosselin B, Leclet H, Marie A, Sebert JL, Lemaguer D, Lelievre G: Primary hyperoxaluria diagnosed after renal transplantation. J Nephrol 1:43–45, 1989
  8. Smith LH: Primary hyperoxaluria, the effect of long-term treatment. (abstract) Urol Res 14:95, 1986
  9. Barratt TM, von Sperling V, Dillon MJ, Rose GA, Trompeter RS: Primary hyperoxaluria in children, in Oxalate Metabolism in Relation to Urinary Stone edited by Rose GA, New York, Springer-Verlag, 1988, pp. 83–102
  10. Broyer M, Brunner FP, Brynger Dykes SR, Ehrich JHH, Fassbinder W, Geerlings W, Rizzoni G, Selwood NH, Tufveson G, Wing AJ: Kidney transplantation in primary oxalosis. PEDTA (in press)
  11. Danpure CJ: Personal Communication 12 Mar 90. MRC Clinical Research Centre, Division of Clinical Cell Biology, Watford Road, Harrow, Middlesex HA13UJ, U.K.
  12. Coe FL, Boyce WH, Friedman GD, ET AL: Prevention and treatment of kidney stones, in NIH Consensus Development Conference Statement 7(1):1–8, 1988
  13. Robertson WG, Peacock M, Marshall RW, Marshall DH, Nordin BEC: Saturation-inhibition index as a measure of the risk of calcium oxalate stone formation in the urinary tract. N Engl J Med 294:249–252, 1976 | PubMed | ChemPort |
  14. Pak CYC: Physicochemical basis for formation of renal stones of calcium phosphate origin: Calculation of the degree of saturation of urine with respect to brushite. J Clin Invest 48:1914–1922 | PubMed | ISI | ChemPort |
  15. Parks JH, Coe FL: Urinary calcium-citrate index for the evaluation of nephrolithiasis. Kidney Int 30:85–90, 1986 | PubMed | ISI | ChemPort |
  16. Liu ST, Hurwitz A, Nancollas GH: The influence of polyphosphate ions on the precipitation of calcium oxalate. J Urol 127:351–355, 1982
  17. Worcester EM, Nakagawa Y, Coe FL: Glycoprotein calcium oxalate crystal growth inhibitor in urine. Miner Electrol Metab 13:267–272, 1987
  18. Zerwekh JE, Drake E, Gregory J, Griffith D, Hofmann AF, Menon M, Pak CYC: Assay of urinary oxalate: Six methodologies compared. Clin Chem 29:1977–1980, 1983 | PubMed | ISI | ChemPort |
  19. Samuell CT: Experiences with an external quality assessment scheme for urinary oxalate, in Oxalate Metabolism in Relation to Urinary Stone edited by Rose GA, New York, Springer-Verlag, 1988, pp. 27–44
  20. Kasidas GP: Assaying of oxalate in plasma, in Oxalate Metabolism in Relation to Urinary Stone edited by Rose GA, New York, Springer-Verlag, 1988, pp. 45–64
  21. Ng RH, Menon M, Ladenson JH: Collection and handling of 24-hour urine specimens for measurement of analytes related to renal calculi. Clin Chem 30:467–471, 1984
  22. Leumann E, Dietl A, Matasovic A: Urinary oxalate and glycolate in healthy infants and children. Pediatric Nephrol 4:493–497, 1990
  23. Morgenstern BZ, Milliner DS, Simmons PS, Smith LH, Wilson DM, Moyer T, DeBernardi M: Developmental patterns of urinary oxalate (OX) and glycolate (GLY) excretion during the first year of life. (abstract) Ped Nephrol 3:C153, 1989
  24. Gabow PA: Ethylene glycol intoxication. Am J Kidney Dis 11(3):277–279, 1988
  25. Nakatani T, Kawasaki Y, Minatogawa Y, Okuno E, Kido R: Peroxisome localized human hepatic alanine-glyoxylate aminotransferase and its application to clinical diagnosis. Clin Biochem 18:311–316, 1985
  26. Danpure CJ, Jennings PR: Peroxisomal alanine: Glyoxylate aminotransferase deficiency in primary hyperoxaluria type I. FEBS J 201(1):20–24, 1986
  27. Danpure CJ, Purkiss P, Jennings PR, Watts RWE: Mitochondrial damage and the subcellular distribution of 2-oxoglutarate: Glyoxylate carboligase in normal human and rat liver and in the liver of a patient with primary hyperoxaluria type I. Clin Sci 70:417–425, 1986
  28. Iancu TC, Danpure CJ: Primary hyperoxaluria type I: Ultrastructural observations in liver biopsies. J Inherited Metab Dis 10(4):330–338, 1987
  29. Wise PJ, Danpure CJ, Jennings PR: Immunological heterogeneity of hepatic alanine:glyoxylate aminotransferase in primary hyperoxaluria type I. FEBS J 222(1):17–20, 1987
  30. Schutgens RBH, Schrakamp G, Wanders RJA, Heymans HSA, Tager JM, van den Bosch H: Prenatal and perinatal diagnosis of peroxisomal disorders. J Inher Metab Dis 12(1):118–134, 1989
  31. Danpure CJ, Jennings PR: Further studies on the activity and subcelular distribution of alanine:glyoxylate aminotransferase in the livers of patients with hyperoxaluria Type 1. Clin Sci 75:315–322, 1988 | PubMed | ChemPort |
  32. Cooper PJ, Danpure CJ, Wise PJ, Guttridge KM: Immunocytochemical localization of human hepatic alanine:glyoxylate aminotransferase in control subjects and patients with primary hyperoxaluria type. J Histochem Cytochem 36(10):1285–1294, 1988 | PubMed | ChemPort |
  33. Danpure CJ, Cooper PJ, Wise PJ, Jennings PR: An enzyme trafficking defect in two patients with primary hyperoxaluria type 1: Peroxisomal alanine/glyoxylate aminotransferase rerouted to mitochondria. J Cell Biol 108:1345–1352, 1989 | Article | PubMed | ChemPort |
  34. Allsop J, Jennings PR, Danpure CJ: A new micro-assay for human liver alanine:glyoxylate aminotransferase. Clin Chim Acta 170:187–194, 1987 | Article | PubMed | ISI | ChemPort |
  35. Danpure CJ, Jennings PR, Watts RWE: Enzymological diagnosis of primary hyperoxaluria type 1 by measurement of hepatic alanine:glyoxylate aminotransferase activity. Lancet 1:289–291, 1987 | PubMed | ChemPort |
  36. de Zegher FE, Wolff ED, van der Heijden AJ, Sukhai RN: Oxalosis in infancy. (Review) Clin Nephrol 22(3):P114–120, 1984
  37. Leumann EP, Niederwieser A, Fanconi A: New aspects of infantile oxalosis. Pediatr Nephrol 1:531–535, 1987
  38. Personal Communication:Dr. S.M. Mauer, whose concept of PHI as a metabolic malignancy encouraged our aggressive approach to management
  39. Perdue PE, Danpure CE: Molecular Genetics (in press)
  40. Danpure CJ, Jennings PR, Penketh RJ, Wise PJ, Cooper PJ, Rodeck CH: Fetal liver alanine:glyoxylate aminotransferase and the prenatal diagnosis of primary hyperoxaluria type 1. Prenatal Diag 9:271–281, 1989
  41. Danpure CJ: Peroxisomal alanine:glyoxylate aminotransferase and prenatal diagnosis of primary hyperoxaluria type I. Lancet 2:1168, 1986
  42. Prenen JAC, Dorhout Mees EJ, Boer P, Endeman HJ, Ephraim KH: Oxalic acid concentration in serum measured by isotonic clearance technique. Experience in hyper- and normooxaluric subjects. Proc EDTA 16:566–571, 1979
  43. Williams HE, Johnson GA, Smith LH Jr: The renal clearance of oxalate in normal subjects and patients with primary hyperoxaluria. Clin Sci 41:213–218, 1971
  44. Constable AR, Joekes AM, Kasidas GP, O'regan P, Rose GA: Plasma level and renal clearance of oxalate in normal subjects and in patients with primary hyperoxaluria or chronic renal failure or both. Clin Sci 56:299–304, 1979
  45. Akcay T, Rose GA: The real and apparent oxalate in plasma. Clin Chim Acta 101:82–86, 1980
  46. Wolthers BG, Hayer M: The determination of oxalic acid in plasma and urine by means of capillary gas chromatography. Clin Chim Acta 120:87–102, 1982
  47. Lopez M, Tuchman M, Scheinman JI: Capillary gas chromatography measurement of oxalate in plasma and urine. Kidney Int 28:82–84, 1985
  48. Scheinman JI, Gale Diane, Roe CR, Millington DS: Reliable measurement of urine and plasma oxalate by GC/MS. Kidney Int (abstract) 27:126, 1985
  49. Millington DS, Maltby DA, Gale DA, Matchar DA, Scheinman JI: Isotope dilution assays for oxalate and methylmalonate. Proc Am Soc Mass Spec San Diego, Ca, 1985
  50. Scheinman J, Fallon M, Small K, Mahan J, Letson R, Klintworth G: Primary hyperoxaluria (PHO): Common mitogenic effects on bone and retina. (abstract) IPNA 1989
  51. Scheinman JI, Fallon MJ, Mahan J: Quantitative bone histomorphometry is oxalosis—serial biopsy analysis. (abstract) National Kidney Foundation 2 Dec, 1989
  52. Day DL, Scheinman JI, Mahan J: Radiological aspects of primary hyperoxaluria. Am J Roent 146:359–401, 1986
  53. Small KW, Letson R, Schienman JI: Ocular findings in primary hyperoxaluria. Arch Ophthalmol 108:89–93, 1990 | PubMed | ISI | ChemPort |
  54. Worcester EM, Nakagawa Y, Bushinsky DA, Coe FL: Evidence that serum calcium oxalate supersaturation is a consequence of oxalate retention in patients with chronic renal failure. J Clin Invest 77(6):1888–1896, 1986 | PubMed | ISI | ChemPort |
  55. Yendt ER, Cohanim M: Response to a physiologic dose of pyridoxine in type I primary hyperoxaluria. N Engl J Med 312:953–957, 1985
  56. Watts RWE: Hyperoxaluria, in Clinical and physiological applications of vitamin B-6. Cur Top NutrDis 19:245–261, 1988
  57. Smith LH Jr, Williams HE: Treatment of primary hyperoxaluria. (abstract) Mod Treat 4:522, 1967
  58. Scheinman JI, Najarian JS, Mauer SM: Successful strategies for renal transplantation in primary oxalosis. Kidney Int 25:804–811, 1984 | PubMed | ISI | ChemPort |
  59. Scheinman JI: The management of primary hyperoxaluria. Kidney Int 17:13–17, 1984
  60. Thomas WC: Use of phosphates in patients with calcareous renal calculi. Kidney Int 13:390–396, 1978
  61. Coe FL, Parks JH: Physical chemistry of calcium stone disease, in Nephrolithiasis, Pathogenesis and Treatment. Chicago, Yearbook Medical Publishers, 1988, p. 54
  62. Kok DJ, Papapoulos SE, Blomen LJMJ, Bijovet OLM: Modulation of calcium oxalate monohydrate crystallization kinetics in vitro. Kidney Int 34:346–350, 1988 | PubMed |
  63. Lemann J, Gray R, Pleuss J: Potassium bicarbonate, but not sodium bicarbonate, reduces urinary calcium excretion and improves calcium balance in healthy men. Kidney Int 35:688–695, 1989 | PubMed | ISI |
  64. Goldberg H, Grass L, Vogl R, Rapoport A, Oreopoulos DG: Urine citrate and renal stone disease. Can Med Assoc J 141(3):217–222, 1989
  65. Thompson CS, Weinman EJ: The significance of oxalate in renal failure. Am J Kid Dis 4:97–100, 1984
  66. de Hoek CT, Diderich PNM, Gratama S, Weijs-v Hofwegen EJM: Oxalosis in chronic renal failure. Proc EDTA 17:730–735, 1980
  67. Oren A, Husdan H, Cheng PT, Khanna R, Pierratos A, Digenis G, Oreopoulos DG: Calcium oxalate kidney stones in patients on continuous ambulatory peritoneal dialysis. Kidney Int 25:534–538, 1984
  68. Morgan SH, Purkiss P, Watts RW, Mansell MA: Oxalate dynamics in chronic renal failure. Comparison with normal subjects and patients with primary hyperoxaluria. Nephron 46(3):253–257, 1987 | PubMed | ChemPort |
  69. Watts RWE: Timing of renal transplantation in the management of pyridoxine resistant type I primary hyperoxaluria. Transplantation 45(6):1143–1145, 1988 | PubMed | ChemPort |
  70. Mansell MA, Watts RWE: Renal failure and transplantation in primary hyperoxaluria, in Oxalate Metabolism in Relation to Urinary Stone edited by Rose GA, New York, Springer-Verlag, 1988, pp. 167–174
  71. Drachman R, Dollberg L, Drukker A: Oxalate deposition in a renal transplant during cyclosporin-A (CsA) therapy. (abstract) Pediatr Nephrol 1(4):C109, 1987
  72. So SK, Najarian JS, Nevins TE, Fryd DS, Knaak M, Chavers B, Mauer SM, Simmons RL: Low-dose cyclosporine therapy combined with standard immunosuppression in pediatric renal transplantation. J Pediatr 111(6 Pt 2):1017–1021, 1987
  73. Watts RWE, Calne RY, Williams R, Mansell MA, Veall N, Purkiss P, Rolles K: Primary hyperoxaluria (type I): Attempted treatment by combined hepatic and renal transplantation. Quart J Med 57(222):697–703, 1985
  74. Watts RWE, Calne RY, Rolles K, Danpure CJ, Morgan SH, Mansell MA, Williams R, Purkiss P: Successful treatment of primary hyperoxaluria type I by combined hepatic and renal transplantation. Lancet 2(8557):474–475, 1987 | PubMed | ChemPort |
  75. Murphy J, Vaughn WK: Preliminary Communication. Transplantation Data Pitt-UNOS. Liver Transplant Registry, 14 Mar 1990
  76. McDonald JC, Landreneau MD, Rohr MS, De Vault GA Jr: Reversal by liver transplantation of the complications of primary hyperoxaluria as well as the metabolic defect. N Engl J Med 321:1100–1102, 1989
  77. Weisner RE, Smith LH: (Mayo Clinic) Personal Communication, 1990
  78. Personal communication, Dr. Eileen Sedman, U. Michigan Hospitals, Ann Arbor, MI
  79. Personal communication, J Murphy, and WK Vaughn Pitt-Unos Liver Transplant Registry, Pittsburgh, PA
  80. Katz A, Kim Y, Scheinman JI, Najarian S, Mauer M: Long-term outcome of kidney transplantation in children with oxalosis. Transplant Proc 21(1):2033–2035, 1989 | PubMed | ChemPort |
  81. Cochat P, Faure JL, Divr P, Danpure CJ, Descos B, Wright C, Takvorian P, Floret D: Liver transplantation in primary hyperoxaluria type I. Lancet 1:1142–1143, 1989 | PubMed | ChemPort |

Extra navigation

.
ADVERTISEMENT